文献速递腹部技术与安全MR

减少不适当的增强MRCP检查:嵌入电子病历的临床诊疗路径的影响

Decreasing inappropriate MRCP with contrast exams: impact of an EMR-Embedded clinical care pathway.
PubMed 文献 · Abdom Radiol (NY) · 2025-05-29

本研究通过移除电子病历中两种MRCP医嘱并建立含临床指导的MRCP临床诊疗路径,评估其对急诊和住院患者增强MRCP比例及临床适当性的影响。结果显示增强MRCP比例从71%降至56%(相对降低22%,p=0.003),不适当增强MRCP医嘱从54%降至25%(相对降低53%,p=0.007),增强MRCP平均「在室」时间延长11.5分钟。

要点

  • 建立嵌入电子病历的MRCP临床诊疗路径后,增强MRCP比例从71%降至56%(p=0.003)。
  • 不适当增强MRCP医嘱从54%降至25%(相对降低53%,p=0.007)。
  • 增强MRCP平均「在室」时间比平扫MRCP长11.5分钟。

核心结论

  • 尽管有临床决策支持工具,基线时54%的增强MRCP医嘱被判定为不适当;通过建立含临床指导的诊疗路径重新设计MRCP开单流程,使增强MRCP比例相对降低22%,并使增强MRCP检查的相对临床适当性改善62%。

研究设计与样本

  • 质量改进项目,采用计划-实施-研究-行动(PDSA)循环;基线随机审查200例MRCP医嘱(增强142例、平扫58例),PDSA第1周期后重新评估36例增强MRCP医嘱;比较增强与平扫MRCP的MRI资源使用(人工追踪「患者在室」时间);研究期间全程使用商业临床决策支持(CDS)工具;采用卡方检验评估统计学显著性。

诊断标准与关键数值

  • 基线时增强MRCP占71%(142/200),平扫MRCP占29%(58/200)。
  • 两个PDSA循环后,增强MRCP比例降至56%(p=0.003,相对降低22%),平扫MRCP比例升至44%(相对增加53%)。
  • 基线时54%(29/54)的增强MRCP检查被判定为不适当;PDSA第1周期后不适当增强MRCP医嘱降至25%(9/36),相对降低53%(p=0.007)。
  • 增强MRCP的平均「在室」时间比平扫MRCP长11.5分钟。

临床应用与阅片要点

  • 本研究中心将两种MRCP医嘱从电子病历中移除,并将所有开单者引导至新的MRCP临床诊疗路径,该路径包含临床指导及基于适应证和患者特征链接至适当医嘱。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Decrease unnecessary abdominal MRI with intravenous contrast with MRCP exams for emergency department and inpatients.

METHODS: Our institution's two MRCP orders were removed from the electronic medical record (one with intravenous (IV) contrast and the other without), with all providers directed to a new MRCP clinical care pathway containing clinical guidance and links to the appropriate orders based on indication and patient characteristics. Before and after deployment, a random set of MRCP with contrast orders were reviewed for clinical appropriateness of needing IV contrast. A manual tracking of "patient in room" time was performed to compare MRI resource use for MRCP exams with contrast vs. non-contrast. A commercial clinical decision support (CDS) tool was active throughout the study period. Statistical significance was assessed with Chi-square test.

RESULTS: At baseline, 71% (142/200) of MRCP exams were completed with contrast and 29% (58/200) without contrast. After two plan-do-study-act (PDSA) cycles, percentage of MRCPs performed with contrast decreased to 56% (p = 0.003), a 22% relative decrease, and MRCPs performed without contrast increased to 44%, a 53% relative increase. At baseline, contrast use was deemed inappropriate in 54% (29/54) of MRCP studies. Reassessment after PDSA cycle 1 showed a decrease in inappropriate MRCP with contrast orders to 25% (9/36), a 53% relative decrease (p = 0.007). Mean "in room" time was 11.5 min longer for MRCP with contrast exams.

CONCLUSION: Despite CDS, MRCP with contrast orders were deemed inappropriate 54% of the time at baseline. Redesigning the MRCP ordering process via creation of a pathway with embedded clinical guidance significantly decreased the proportion of contrast-enhanced MRCP exams by 22% and improved relative clinical appropriateness of MRCP with contrast exams by 62%. Properly directing ordering providers to non-contrast MRCP orders can help reduce healthcare costs, reduce unnecessary gadolinium exposure, and improve MR scanner efficiency.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Asch D, Gunabushanam G, Cole K, et al. Decreasing inappropriate MRCP with contrast exams: impact of an EMR-Embedded clinical care pathway. Abdom Radiol (NY). 2025. PMID: 40439723. doi:10.1007/s00261-025-05022-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。